Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2019
US pharma companies really do want Britain to pay more for drugs
6 December 2019 - When President Donald Trump arrived in the United Kingdom this week, he landed bang in the ...
Posted by Michael Wonder on 06 Dec 2019
Proposed changes to research and development tax incentive will discourage investment and undermine innovation
6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...
Posted by Michael Wonder on 04 Dec 2019
Labor unions team up with drug makers to defeat drug-price proposals
3 December 2019 - A low-profile group, financed by the pharmaceutical industry, has hired former union officials to oppose drug-price proposals ...
Posted by Michael Wonder on 04 Dec 2019
Drug makers strongly oppose post-approval evaluation
4 December 2019 - The pharmaceutical industry adamantly criticised the government’s plan to evaluate expensive anti-cancer therapies and orphan drugs, ...
Posted by Michael Wonder on 04 Dec 2019
'Cannot be trusted ... causing harm': top medical journal takes on big pharma
4 December 2019 - A leading medical journal is launching a global campaign to separate medicine from big pharma, linking ...
Posted by Michael Wonder on 03 Dec 2019
Does the Institute for Clinical and Economic Review revise its findings in response to industry comments?
2 December 2019 - The ICER has gained prominence through its work conducting health technology assessments of pharmaceuticals in the United ...
Posted by Michael Wonder on 27 Nov 2019
Pharma execs tell researchers that multiple sclerosis drug pricing is based on competition, not R&D costs
26 November 2019 - Despite claims that prices for new medicines are generally shaped by R&D costs, initial pricing decisions ...
Posted by Michael Wonder on 26 Nov 2019
Teva, drug makers in talks with U.S. to end generics probes
26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...
Posted by Michael Wonder on 22 Nov 2019
Corbyn pledges to create state-run generics firm to cut drug prices
22 November 2019 - Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run ...
Posted by Michael Wonder on 22 Nov 2019
Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years
21 November 2019 - International reference pricing provisions in plan would decimate development of innovative medicines by nearly 90%. ...
Posted by Michael Wonder on 19 Nov 2019
Here’s why pharmaceutical companies raise their prices so much
19 November 2019 - Yes, I’ve ranted about healthcare prices before. On more than one occasion. ...
Posted by Michael Wonder on 14 Nov 2019
Drug companies exaggerate — controlling drug prices won't threaten innovation
13 November 2019 - It is hard to not be impressed by the progress Americans have made in combatting diseases. ...
Posted by Michael Wonder on 26 Oct 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort study
23 October 2019 - This study determined the extent to which late stage development of new drugs relies on support from ...
Posted by Michael Wonder on 25 Oct 2019
Making new drugs is hard. So is pricing them.
25 October 2019 - What's harder, making new drugs, or pricing them? ...
Posted by Michael Wonder on 22 Oct 2019
Can we stop the medicine arms race?
22 October 2019 - Patients at risk of “exploitative manipulation” from medicines lobbyists if PBS politicisation continues, doctor tells parliament ...